Get 20% lifetime commission for referring investors to digrin.com
here.
MacroGenics, Inc. ( MGNX) - Key Metrics
MGNX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.52 | $0.31 | -$0.64 | -$0.65 |
| 2026Q1 | $0.33 | -$0.58 | -$0.56 | -$0.57 |
| 2025Q4 | $0.65 | -$0.22 | $0.68 | $0.68 |
| 2025Q3 | $1.15 | $0.27 | -$0.48 | -$0.48 |
| 2025Q2 | $0.35 | -$0.57 | -$0.74 | -$0.76 |
MGNX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 3.73 |
| 2026Q1 | 0% | -1.25 |
| 2025Q4 | 0% | -1.83 |
| 2025Q3 | 0% | 1.56 |
| 2025Q2 | 0% | -0.53 |
MGNX
Price: $4.11
52 week price:
Earnings Per Share: -1.64 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 382181
Ebitda: -45.8 millionMarket Capitalization: 258.6 million